These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27018059)

  • 1. Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approaches.
    López-Pedrera C; Barbarroja N; Jimenez-Gomez Y; Collantes-Estevez E; Aguirre MA; Cuadrado MJ
    Rheumatology (Oxford); 2016 Dec; 55(12):2096-2108. PubMed ID: 27018059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR; Simpson DF; Hurley BL; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune-mediated atherothrombosis.
    Matsuura E; Lopez LR
    Lupus; 2008 Oct; 17(10):878-87. PubMed ID: 18827052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
    Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment.
    Ruiz-Limon P; Barbarroja N; Perez-Sanchez C; Aguirre MA; Bertolaccini ML; Khamashta MA; Rodriguez-Ariza A; Almadén Y; Segui P; Khraiwesh H; Gonzalez-Reyes JA; Villalba JM; Collantes-Estevez E; Cuadrado MJ; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1450-8. PubMed ID: 24658835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients'.
    Pérez-Sánchez C; Aguirre MA; Ruiz-Limón P; Barbarroja N; Jiménez-Gómez Y; de la Rosa IA; Rodriguez-Ariza A; Collantes-Estévez E; Segui P; Velasco F; Cuadrado MJ; Teruel R; González-Conejero R; Martínez C; López-Pedrera Ch
    Sci Rep; 2016 Aug; 6():31375. PubMed ID: 27502756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of atherosclerosis and cardiovascular disease in antiphospholipid syndrome and systemic lupus erythematosus. New therapeutic approaches.
    Lopez-Pedrera C; Aguirre-Zamorano MÁ; Pérez-Sánchez C
    Med Clin (Barc); 2017 Aug; 149(4):160-169. PubMed ID: 28619369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress and Treg depletion in lupus patients with anti-phospholipid syndrome.
    Lai ZW; Marchena-Mendez I; Perl A
    Clin Immunol; 2015 Jun; 158(2):148-52. PubMed ID: 25862984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils-Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
    Wirestam L; Arve S; Linge P; Bengtsson AA
    Front Immunol; 2019; 10():2734. PubMed ID: 31824510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Hurley BL; Lopez LR
    Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile: A Randomized, Placebo-Controlled Trial.
    Pérez-Sánchez C; Aguirre MÁ; Ruiz-Limón P; Ábalos-Aguilera MC; Jiménez-Gómez Y; Arias-de la Rosa I; Rodriguez-Ariza A; Fernández-Del Río L; González-Reyes JA; Segui P; Collantes-Estévez E; Barbarroja N; Velasco F; Sciascia S; Cecchi I; Cuadrado MJ; Villalba JM; López-Pedrera C
    Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1923-1932. PubMed ID: 28684614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerosis, oxidative stress and auto-antibodies in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Alves JD; Ames PR
    Immunobiology; 2003; 207(1):23-8. PubMed ID: 12638899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis.
    Romero FI; Khamashta MA; Hughes GR
    Lupus; 2000; 9(3):206-9. PubMed ID: 10805489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
    Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
    Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus.
    Salem D; Subang R; Laplante P; Levine JS; Rauch J
    Lupus; 2014 Oct; 23(12):1327-31. PubMed ID: 25228740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.